Consistent with the above findings, we recently performed a synthetic lethality screen using shRNA libraries in HNSCC cell lines and found that co-targeting numerous molecules involved in ERK/MAPK pathway sensitizes the growth suppressive activities of mTOR inhibition. This evidence concerns the gene MTOR and head and neck squamous cell carcinoma.